8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine

C42H40BClN12O2 — CID 159293110

IUPAC8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine
SMILESCC1(C)OB(c2cnn(-c3cccnc3)c2)OC1(C)C.Clc1ccc2c(n1)-c1[nH]ncc1CC2.c1cncc(-n2cc(-c3ccc4c(n3)-c3[nH]ncc3CC4)cn2)c1
InChIInChI=1S/C18H14N6.C14H18BN3O2.C10H8ClN3/c1-2-15(10-19-7-1)24-11-14(9-21-24)16-6-5-12-3-4-13-8-20-23-18(13)17(12)22-16;1-13(2)14(3,4)20-15(19-13)11-8-17-18(10-11)12-6-5-7-16-9-12;11-8-4-3-6-1-2-7-5-12-14-10(7)9(6)13-8/h1-2,5-11H,3-4H2,(H,20,23);5-10H,1-4H3;3-5H,1-2H2,(H,12,14)
InChIKeyLAJKJOHRZPYOBF-UHFFFAOYSA-N
MW791.13 g/mol
LogP6.61
Rot. Bonds4

About 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine

8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine (PubChem CID 159293110) has the molecular formula C42H40BClN12O2 and a molecular weight of 791.13 g/mol. Its IUPAC name is 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine.

Molecular Properties

Compound Name8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine
PubChem CID159293110
Molecular FormulaC42H40BClN12O2
Molecular Weight791.13 g/mol
Exact Mass790.32
IUPAC Name8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine
SMILESCC1(C)OB(c2cnn(-c3cccnc3)c2)OC1(C)C.Clc1ccc2c(n1)-c1[nH]ncc1CC2.c1cncc(-n2cc(-c3ccc4c(n3)-c3[nH]ncc3CC4)cn2)c1
InChIInChI=1S/C18H14N6.C14H18BN3O2.C10H8ClN3/c1-2-15(10-19-7-1)24-11-14(9-21-24)16-6-5-12-3-4-13-8-20-23-18(13)17(12)22-16;1-13(2)14(3,4)20-15(19-13)11-8-17-18(10-11)12-6-5-7-16-9-12;11-8-4-3-6-1-2-7-5-12-14-10(7)9(6)13-8/h1-2,5-11H,3-4H2,(H,20,23);5-10H,1-4H3;3-5H,1-2H2,(H,12,14)
InChIKeyLAJKJOHRZPYOBF-UHFFFAOYSA-N
XLogP6.61
TPSA163.02 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds4
Heavy Atoms58
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500791.13
LogP ≤ 56.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine?
The IUPAC name of 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine (CID 159293110) is 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine.
What is the SMILES notation for 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine?
The canonical SMILES for 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine is CC1(C)OB(c2cnn(-c3cccnc3)c2)OC1(C)C.Clc1ccc2c(n1)-c1[nH]ncc1CC2.c1cncc(-n2cc(-c3ccc4c(n3)-c3[nH]ncc3CC4)cn2)c1.
What is the InChIKey of 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine?
The InChIKey is LAJKJOHRZPYOBF-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H14N6.C14H18BN3O2.C10H8ClN3/c1-2-15(10-19-7-1)24-11-14(9-21-24)16-6-5-12-3-4-13-8-20-23-18(13)17(12)22-16;1-13(2)14(3,4)20-15(19-13)11-8-17-18(10-11)12-6-5-7-16-9-12;11-8-4-3-6-1-2-7-5-12-14-10(7)9(6)13-8/h1-2,5-11H,3-4H2,(H,20,23);5-10H,1-4H3;3-5H,1-2H2,(H,12,14).
What are the key properties of 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine?
8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine has a molecular weight of 791.13 g/mol, XLogP of 6.61, 4 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 8-chloro-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;8-(1-pyridin-3-ylpyrazol-4-yl)-4,5-dihydro-1H-pyrazolo[4,5-h]quinoline;3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]pyridine is sourced from PubChem (CID 159293110), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).